24 participants
Real-World Evidence of Effectiveness and Safety of Tirabrutinib in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma in Taiwan: A Nationwide Study
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-05-20
- Start Date:
- 2025-02-03
- Completion:
- 2026-03-31
Conditions
- Primary Central Nervous System Lymphoma (PCNSL)
No Results Yet